Chemotherapy‐induced peripheral neurotoxicity (CIPN): what we need and what we know
- 1 June 2014
- journal article
- lecture
- Published by Wiley in Journal of the Peripheral Nervous System
- Vol. 19 (2) , 66-76
Abstract
Chemotherapy-induced peripheral neurotoxicity (CIPN) is one of the most frequent and severe long-term side effects of cancer chemotherapy. Preclinical and clinical studies have extensively investigated CIPN searching for effective strategies to limit its severity or to treat CIPN-related impairment, but the results have been disappointing. Among the reasons for this failure are methodological flaws in both preclinical and clinical investigations. Their successful resolution might provide a brighter perspective for future studies. Among the several neurotoxic chemotherapy drugs, oxaliplatin may offer a clear example of a methodological approach eventually leading to successful clinical trials. However, the same considerations apply to the other neurotoxic agents and, although frequently neglected, also to the new "targeted" agents.Keywords
This publication has 90 references indexed in Scilit:
- Carfilzomib in multiple myeloma patients with renal impairment: pharmacokinetics and safetyLeukemia, 2013
- Animal Models of Peripheral NeuropathiesNeurotherapeutics, 2012
- Healthcare Costs and Workloss Burden of Patients with Chemotherapy-Associated Peripheral Neuropathy in Breast, Ovarian, Head and Neck, and Nonsmall Cell Lung CancerChemotherapy Research and Practice, 2012
- Survival in BRAF V600–Mutant Advanced Melanoma Treated with VemurafenibNew England Journal of Medicine, 2012
- Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathyExperimental Neurology, 2011
- The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CASupportive Care in Cancer, 2011
- The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trialSupportive Care in Cancer, 2010
- Differential Expression of ATP7A, ATP7B and CTR1 in Adult Rat Dorsal Root Ganglion TissueMolecular Pain, 2010
- Comparison of Oxaliplatin- and Cisplatin-Induced Painful Peripheral Neuropathy in the RatThe Journal of Pain, 2009
- Novel tubulin-targeting agents: anticancer activity and pharmacologic profile of epothilones and related analoguesAnnals of Oncology, 2007